| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.23B | -8.3% |
| Cost of Revenue | $4.01B | -3.3% |
| Gross Profit | $2.22B | -16.2% |
| R&D Expense | $38.9M | -1.0% |
| SG&A Expense | $1.70B | -8.2% |
| Operating Income | $519.5M | -34.9% |
| Interest Expense | $157.1M | -3.7% |
| Pre-tax Income | $352.7M | -39.3% |
| Income Tax | $483.9M | +705.1% |
| Net Income | -$127.2M | -264.7% |
| EPS (Basic) | -$0.36 | -263.6% |
| EPS (Diluted) | -$0.36 | -263.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $238.4M | -55.5% |
| Accounts Receivable | $721.4M | -19.3% |
| Inventory | $1.98B | +25.0% |
| Current Assets | $3.13B | -11.2% |
| Total Assets | $6.50B | -8.0% |
| Current Liabilities | $1.79B | -23.1% |
| Long-term Debt | $3.61B | +8.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$358.8M | -157.6% |
| Capital Expenditures | $112.1M | +61.9% |
| Investing Cash Flow | -$216.4M | -312.6% |
| Financing Cash Flow | $295.8M | +133.3% |
| Free Cash Flow | -$470.9M | -185.0% |
| Total Liabilities |
| $6.11B |
| -4.1% |
| Stockholders' Equity | $398.3M | -43.3% |